The company's principal activities are to develop, manufacture and market various immunodiagnostic kits for the detection of cancer and other diseases. The products of the company are used by hospital, clinical, research and forensic laboratories and doctors' offices to obtain precise and rapid identification of certain types of cancer and other diseases. The company has two primary kits: dr-70(R) and pylori-probe. Dr-70(R) testing kit is used for the detection of 13 different types of cancers including cancer of lung, stomach, breast, rectal, colon and liver. Pylori-probe is an in vitro diagnostic testing kit, which is used for the detection of helicobacter pylori, a bacterium that colonizes the mucus lining associated with gastric and peptic ulcers. The products are primarily marketed in Europe and Asia.
